We have located links that may give you full text access.
Use of a neural network to predict normalized signal strengths from a DNA-sequencing microarray.
Bioinformation 2017
A microarray DNA sequencing experiment for a molecule of N bases produces a 4xN data matrix, where for each of the N positions each quartet comprises the signal strength of binding of an experimental DNA to a reference oligonucleotide affixed to the microarray, for the four possible bases (A, C, G, or T). The strongest signal in each quartet should result from a perfect complementary match between experimental and reference DNA sequence, and therefore indicate the correct base call at that position. The linear series of calls should constitute the DNA sequence. Variation in the absolute and relative signal strengths, due to variable base composition and other factors over the N quartets, can interfere with the accuracy and (or) confidence of base calls in ways that are not fully understood. We used a feed-forward back-propagation neural network model to predict normalized signal intensities of a microarray-derived DNA sequence of N = 15,453 bases. The DNA sequence was encoded as n-gram neural input vectors, where n = 1, 2, and their composite. The data were divided into training, validation, and testing sets. Regression values were >99% overall, and improved with increased number of neurons in the hidden layer, and in the composition n-grams. We also noticed a very low mean square error overall which transforms to a high performance value.
Full text links
Related Resources
Trending Papers
Heart failure with preserved ejection fraction: diagnosis, risk assessment, and treatment.Clinical Research in Cardiology : Official Journal of the German Cardiac Society 2024 April 12
Proximal versus distal diuretics in congestive heart failure.Nephrology, Dialysis, Transplantation 2024 Februrary 30
Efficacy and safety of pharmacotherapy in chronic insomnia: A review of clinical guidelines and case reports.Mental Health Clinician 2023 October
World Health Organization and International Consensus Classification of eosinophilic disorders: 2024 update on diagnosis, risk stratification, and management.American Journal of Hematology 2024 March 30
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app